Stockholm, Sweden, June 29, 2011
The Nomination Committee of Elekta AB (publ) proposes the following to the company’s Annual General Meeting on September 13, 2011.
The Nomination Committee of Elekta AB (publ) proposes the re-election of Akbar Seddigh, Hans Barella, Luciano Cattani, Vera Kallmeyer, Laurent Leksell, Jan Secher and Birgitta Stymne Göransson as members of the Board. The Nomination Committee also proposes the election of Siaou-Sze Lien and Wolfgang Reim as new members of the Board. Akbar Seddigh is proposed to be re-elected Chairman of the Board. Tommy H. Karlsson, who has served on the Board since 2001, has declined re-election.
Siaou-Sze Lien is currently Senior Executive Coach at Mobley Group Pacific Ltd. after a 28-year career at Hewlett-Packard. Until 2006, Lien was Senior Vice President, Hewlett-Packard Services for the Asia-Pacific & Japan region where she was responsible for accelerating expansions and profitable growth in the world’s most populous and fastest-growing markets. Lien, born in 1950, is a Singapore citizen and holds a BSc in Physics from the Nanyang University in Singapore and an MA in Computer Science from Imperial College of Science and Technology in London. Lien is a board member of Huhtamäki Oy, Luvata Holdings, Republic Polytechnic Singapore and serves on the board of trustees for Nanyang Technological University.
Dr. Reim is currently an independent consultant focusing specifically on the medical technology industry and brings with him more than 25 years of experience from the industry. Until 2006, Dr. Reim was CEO of Dräger Medical AG, a joint venture between Drägerwerk and Siemens. From 1986 to 2000, Dr. Reim was employed with Siemens in Germany and the United States holding a number of leading positions within sales, marketing, development and product management. He was CEO of the Siemens Ultrasound Division from 1997 to 2000 and President of the Special Products Division from 1995 to 1997. Dr. Reim, born in 1956, is a German citizen, holding an MSc (1980) and a PhD in physics (1984) from Eidgenössische Technische Hochchule (ETH) in Zürich. Dr. Reim serves on the boards of GN Store Nord A/S, Carl Zeiss Meditec AG and Esaote S.p.A. He is also a member of the Advisory Board of BB Biotech Ventures.
The full proposal of the Nomination Committee to the Annual General Meeting on September 13, 2011 will be posted in the notice of the Annual General Meeting.
The Nomination Committee consists of Laurent Leksell (Chairman), private and companies’ holdings; Åsa Nisell, Swedbank Robur funds, Anna Ohlsson-Leijon, SEB Funds; Ole E. Dahl, Orkla ASA; and Akbar Seddigh, Chairman of the Board.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today. Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group. Elekta employs around 2,800 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker Elekta. Website: www.elekta.com (http://www.elekta.com/)